TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway-Reference-Cited by-同舟云学术

TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway

Published:2021-06-29 Issue:2 Volume:46 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Zhang Xilin¹,He Ying¹,Jiang Yan¹,Bao Ying²,Chen Qiuqiang²,Xie Dong³,Yu Huanming²,Wang Xiang¹

Affiliation:

1. Department of Central Laboratory, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang 313000, P.R. China

2. Department of Cardiothoracic Surgery, First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang 313000, P.R. China

3. CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole‐Exome Sequencing and Experimental Validation Unveil the Roles of TMEM229A Q200del Mutation in Lung Adenocarcinoma;The Clinical Respiratory Journal;2024-08

2. TMEM205 induces TAM/M2 polarization to promote cisplatin resistance in gastric cancer;Gastric Cancer;2024-06-08

3. Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses;PLOS ONE;2023-12-06

4. TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer;PeerJ;2023-06-29

5. Clinical significance of TMEM229A Q200del mutation in lung adenocarcinoma;2023-06-22